Skip to content

Comparison of effects of Clomiphene citrate and Letrozole on uterine body in infertility patients during ovulation induction using USSR

Comparison of Clomiphene citrate and Letrozole using modified Uterine scoring system for reproduction during cycles of ovulation induction : A double blinded Randomised Control Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070262
Enrollment
92
Registered
2024-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Clomiphene Citrate: 50mg once a day orally From day 2 to day 6 of menstrual cycle Control Intervention1: Letrozole: 2.5 mg once a day orally from day 2 to day 6 of menstrual cycle

Sponsors

AIIMS PATNA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age- 18-40 years 2. BMI- 18-30 kg/m2 3. Normal TSH, Prolactin 4. Patent fallopian tubes

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years or more than 40 years 2. Male factor infertility

Design outcomes

Primary

MeasureTime frame
Endometrial thickness and morphology and vascularityTimepoint: day 13 or 15 of menstrual cycle

Secondary

MeasureTime frame
Myometrial echogenicity and blood flowTimepoint: day 13 or 15 of menstrual cycle;Uterine artery PI, end diastolic flowTimepoint: day 13 or 15 of menstrual cycle

Countries

India

Contacts

Public ContactPragati Sampanna

AIIMS PATNA

indiralh@gmail.com8860033085

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026